Recent trends in orexin research-2010 to 2015

被引：75

作者：

Boss, Christoph ^{[1
]}

Roch, Catherine ^{[2
]}

机构：

[1] Actel Pharmaceut Ltd, Drug Discovery Chem, CH-4123 Allschwil, Switzerland

[2] Actel Pharmaceut Ltd, Drug Discovery Pharmacol, CH-4123 Allschwil, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 15期

关键词：

Orexin; G-protein-coupled receptors; Sleep disorders; Anxiety; Addiction; Hypothalamus; RECEPTOR ANTAGONIST 2-SORA; SLEEP; DISCOVERY; POTENT; TETRAHYDROISOQUINOLINES; HYPOTHALAMUS; HYPOCRETINS; ACT-462206; EXPRESSION; NARCOLEPSY;

D O I：

10.1016/j.bmcl.2015.05.012

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Specific neurons in the lateral hypothalamus produce the orexin neuropeptides (orexin-A and orexin-B). The orexin-peptides are transported to areas of the brain regulating sleep-wake cycles, controlling food intake or modulating emotional states such as panic or anxiety. The orexin system, consisting of the two orexin-neuropeptides and two G-protein-coupled receptors (the orexin-1 and the orexin-2 receptor) is as well involved in reward and addictive behaviors. The review reflects on the most recent activities in the field of orexin research. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：2875 / 2887

页数：13

共 81 条

[21]

Coleman PJ, 2011, CURR TOP MED CHEM, V11, P696

[22]

Congreve M. S., 2014, Patent No. [WO 2014/006402 A1, 2014006402]

[23] The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity [J].

De Lecea, L ;

Kilduff, TS ;

Peyron, C ;

Gao, XB ;

Foye, PE ;

Danielson, PE ;

Fukuhara, C ;

Battenberg, ELF ;

Gautvik, VT ;

Bartlett, FS ;

Frankel, WN ;

van den Pol, AN ;

Bloom, FE ;

Gautvik, KM ;

Sutcliffe, JG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :322-327

[24] Hypocretin (orexin) regulation of sleep-to-wake transitions [J].

de Lecea, Luis ;

Huerta, Ramon .

FRONTIERS IN PHARMACOLOGY, 2014, 5

[25] Hypocretins and the neurobiology of sleep-wake mechanisms [J].

de Lecea, Luis .

OREXIN/HYPOCRETIN SYSTEM, 2012, 198 :15-24

[26]

Drahl C, 2014, CHEM ENG NEWS, V92, P52

[27] Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism [J].

Dugovic, Christine ;

Shelton, Jonathan E. ;

Yun, Sujin ;

Bonaventure, Pascal ;

Shireman, Brock T. ;

Lovenberg, Timothy W. .

FRONTIERS IN NEUROSCIENCE, 2014, 8

[28] Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat [J].

Dugovic, Christine ;

Shelton, Jonathan E. ;

Aluisio, Leah E. ;

Fraser, Ian C. ;

Jiang, Xiaohui ;

Sutton, Steven W. ;

Bonaventure, Pascal ;

Yun, Sujin ;

Li, Xiaorong ;

Lord, Brian ;

Dvorak, Curt A. ;

Carruthers, Nicholas I. ;

Lovenberg, Timothy W. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01) :142-151

[29] LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy [J].

Fitch, Thomas E. ;

Benvenga, Mark J. ;

Jesudason, Cynthia D. ;

Zink, Charity ;

Vandergriff, Amy B. ;

Menezes, Michelle M. ;

Schober, Douglas A. ;

Rorick-Kehn, Linda M. .

FRONTIERS IN NEUROSCIENCE, 2014, 8

[30]

Gaillard P., 2002, PCT Int. Appl. Patent, Patent No. [WO 2002089800, 2002089800]

← 1 2 3 4 5 6 7 8 9 →